Cdk inhibitors: on the threshold of checkpoints and development.
about
Human carbon catabolite repressor protein (CCR4)-associative factor 1: cloning, expression and characterization of its interaction with the B-cell translocation protein BTG1Identification of novel M phase phosphoproteins by expression cloningInteraction of human thymidine kinase 1 with p21(Waf1)Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivoAlpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrestHuman cyclin E, a nuclear protein essential for the G1-to-S phase transitionCrystal structure of the CDK4/6 inhibitory protein p18INK4c provides insights into ankyrin-like repeat structure/function and tumor-derived p16INK4 mutationsRegulatory roles of phosphorylation in model and pathogenic fungiPhosphorylation of the CCAAT displacement protein (CDP)/Cux transcription factor by cyclin A-Cdk1 modulates its DNA binding activity in G(2)HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulationRedistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiationNon-dependence of cyclin E/Cdk2 kinase activity on the initiation of oocyte maturation in goldfish.Cyclins and breast cancer.Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor.Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.A cytoplasmic cell cycle controls the activity of a K+ channel in pre-implantation mouse embryos.Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells.Patterns of p57Kip2 expression in embryonic rat brain suggest roles in progenitor cell cycle exit and neuronal differentiationBiochemical characterization of the human cyclin-dependent protein kinase activating kinase. Identification of p35 as a novel regulatory subunit.Intrinsic and extrinsic regulation of the proliferation and differentiation of cells in the rodent rostral migratory streamRetroviral manipulation of the expression of bone morphogenetic protein receptor Ia by SVZa progenitor cells leads to changes in their p19(INK4d) expression but not in their neuronal commitment.Analysis of the spatial expression pattern of seven Kip related proteins (KRPs) in the shoot apex of Arabidopsis thaliana.UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex.The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawalThe progenitor cells of the embryonic telencephalon and the neonatal anterior subventricular zone differentially regulate their cell cycleInhibition of the cyclin D1/E2F pathway by PCA-4230, a potent repressor of cellular proliferation.The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7.A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination.Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation.Cell cycle-dependent phosphorylation of mammalian protein phosphatase 1 by cdc2 kinase.High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells.Glucocorticoid-stimulated CCAAT/enhancer-binding protein alpha expression is required for steroid-induced G1 cell cycle arrest of minimal-deviation rat hepatoma cells.c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition.A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase
P2860
Q22008021-8FE3F120-86D4-4CAF-9B2B-D49E68FDD4FCQ24315689-A4E0A10B-F9C0-4ED5-A698-BEAD965E1597Q24532825-4973E841-C4A2-4D1E-9AC0-96EBEF49922CQ24554696-CAA74B3A-2E65-4E0B-BDDB-A48E917A01ECQ24648859-F0214458-22D9-4BB0-B02D-9D354712BCCFQ24652527-418E8CC5-5EAC-483C-BD03-4AD0578E8BD4Q27748800-04DE05EB-C612-4CCD-B7D9-8B97DF9897D6Q28087413-2B237073-B32B-44F3-A2BB-632945703287Q28189989-62AAE051-8C9E-40D8-B9D1-2802A8ECB0F8Q28201997-EE827D0F-8F24-45D1-AC93-B941A9792B32Q28205253-E02D27BC-058D-4BE9-80E1-80A4CE4A93CEQ28507371-B9AB9769-E5BD-41F6-B5B8-7EA8E31C45E6Q30887957-1DE6739E-8CB4-4E2F-88D7-2CF7CDE2807AQ33538420-FC56C61F-DAAD-4A22-B178-1B0708F7F49CQ33786424-55E75F89-61DD-446E-AB91-F3DC5B6DF0C8Q33825158-626AC98D-1A16-483B-A7BF-308828A6ABC4Q33853215-4E356540-9210-4BCD-BA74-5024FDD67B90Q33883556-4DF3F752-A303-4F54-8A35-3486557DA955Q33888587-E1F5EB35-1E57-4B99-9C0B-46E9224D10A9Q34162761-2BA289D6-EB13-4E3D-A70E-EEDCCDEE5DF2Q34256767-8F5A6A91-933A-446D-8895-CED404DBEF34Q34370293-CE5D3218-A200-4404-88A4-DC2E2DA1DE35Q34414329-060F99F9-DFE2-48A3-960A-AC2888913EF8Q34414383-76120B95-4114-49B7-BB99-C12F385CAFD4Q34564883-1273C59D-64D7-49E1-9B0C-08C48E762C27Q34640744-9F1DC930-7DEB-46EC-B16D-745AA8FA0D98Q34666832-03BF4C62-64FF-4BFF-8995-23B2744753A7Q34744818-893ED259-99D7-4C23-A53F-3C5DDB0F04F5Q34762590-65B998A3-379D-46F8-BDF0-16FF63FE3139Q35043329-41D0D7C6-8E7A-4D7D-93D1-AE6A08960580Q35211264-5C4BA9C7-8B00-4420-865B-DCE48CF814A1Q35687263-7EBFC39B-8F61-452A-9A84-00B61B34D262Q35870318-5747E1F0-6F41-4C70-A8FD-826166B30255Q36033312-D9839D2C-58FA-47D5-9615-D5B7B30B4A64Q36184676-5E09D003-89B8-4167-A9CB-5FDEA260EEEFQ36397666-118C403B-4F4C-4C3D-ADF2-B774D03B9A33Q36561469-F879A3BB-29DE-4044-8F59-D61DAA44A027Q36562528-C11F16A2-0FE7-455A-95F6-16056B1C65C8Q36573568-EDE92BFE-4970-462A-9CD3-CB5086766BA1Q36574144-8DA8E87C-7467-4196-A83D-9A2AE71D0735
P2860
Cdk inhibitors: on the threshold of checkpoints and development.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cdk inhibitors: on the threshold of checkpoints and development.
@en
type
label
Cdk inhibitors: on the threshold of checkpoints and development.
@en
prefLabel
Cdk inhibitors: on the threshold of checkpoints and development.
@en
P1476
Cdk inhibitors: on the threshold of checkpoints and development.
@en
P2093
P304
P356
10.1016/0955-0674(94)90055-8
P577
1994-12-01T00:00:00Z